Humedix Obtains Syrian Approval for Three Elravie Plus HA Filler Products

Collaboration with Local Partner Talia Medical

Humedix announced on January 12 that it has obtained official product approval in Syria for its hyaluronic acid (HA) filler products: 'Elravie Deep Line Plus 1ml,' 'Elravie Ultra Volume Plus 2ml,' and 'Elravie Light Plus 1ml.'

Humedix

Humedix aims to launch the three approved Elravie Plus products in the Syrian market in March. To achieve this, Humedix plans to collaborate with Talia Medical, a local company that imports and distributes medical devices and cosmetic products in Syria.

Talia Medical will support the stable supply and smooth market entry of the three Elravie Plus products based on its local network and market expertise. Through this partnership, Humedix will provide high-quality HA fillers to medical professionals and consumers in Syria.

Humedix has previously obtained approval and sold Elravie products in numerous countries, including Brazil, China, Iraq, Thailand, and Russia. With this Syrian product approval, the company plans to make a full-scale entry into the Middle Eastern market. The company stated that it will continue to strengthen its product portfolio and expand the number of countries where its products are launched, accelerating its global market expansion.

Kang Minjong, CEO of Humedix, said, "The approval of the three Elravie Plus products in Syria will serve as an important stepping stone for expanding into global markets," adding, "We will continue to provide safe and reliable aesthetic solutions and actively pursue market entry strategies for the Middle East and beyond."